We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

9904:TWSEPou Chen Corporation Analysis

Data as of 2026-03-14 - not real-time

NT$29.50

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Pou Chen trades well below its intrinsic valuation, offering a clear margin of safety. The company’s price‑to‑earnings and price‑to‑book ratios are markedly low, positioning it as a classic value play. A dividend yield that ranks among the highest in its sector provides an attractive income cushion. With a payout ratio comfortably below half of earnings, the dividend appears sustainable. Strong cash reserves offset its elevated debt load, giving the firm flexibility to service obligations. Analyst consensus leans toward a buy, with target prices suggesting substantial upside.
Technically, the stock sits near a key support level and is slightly below its short‑term moving averages. Momentum indicators are neutral to mildly bearish, hinting at limited upside in the near term. However, increasing volume and a low beta suggest that any downside may be contained. Volatility is above average, reflecting the cyclical nature of consumer footwear demand. The blend of defensive dividend income and undervalued fundamentals supports a longer‑run hold. Overall, the balance of valuation upside and modest short‑term risk points to a cautious buying opportunity.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near key support with limited near‑term upside
  • high dividend yield providing income buffer
  • low beta reducing market‑wide volatility exposure

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • undervalued relative to intrinsic DCF estimate
  • forward earnings growth expectations
  • strong cash position supporting debt management

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • sustainable dividend offering steady returns
  • value‑oriented valuation metrics
  • potential upside as market re‑rates cyclical consumer stocks

Key Metrics & Analysis

Financial Health

Revenue Growth-8.20%
Profit Margin4.80%
P/E Ratio7.8
ROE8.12%
ROA2.05%
Debt/Equity34.75
P/B Ratio0.6
Op. Cash FlowNT$14.9B
Free Cash FlowNT$10.4B

Technical Analysis

TrendNeutral
RSI41.7
SupportNT$29.00
ResistanceNT$31.40
MA 20NT$30.40
MA 50NT$30.67
MA 200NT$29.87
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair ValueNT$42.07
Target PriceNT$35.60
Upside/Downside20.68%
GradeUndervalued
TypeValue
Dividend Yield5.76%

Risk Assessment

Beta0.53
Volatility22.89%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.